Transvaginal Mesh Manufacturer, Coloplast, Agrees to $16 Million Settlement of Some Transvaginal Mesh Cases
Officials for Coloplast, a medical device and transvaginal mesh manufacturer based in Denmark, have agreed to pay $16 million to settle some of the transvaginal mesh personal injury lawsuits the company faces in the US.
According to reports, the agreement will settle 400 lawsuits, with payments of about $40,000 per plaintiff.
Other transvaginal mesh manufacturers are also currently in settlement talks.
“It appears that momentum is building for some type of global resolution as more of these vaginal-mesh cases settle,” Carl Tobias, who teaches product-liability law at the University of Richmond in Virginia, said in an e-mail.
“The liability seems pretty clear on these cases, so settlement makes sense,” he said in an earlier interview. “Given how serious the injuries are and the number of cases, when you do the math, you can easily come up with a multibillion-dollar settlement.”
A filing on January 9th in Coloplast’s transvaginal mesh MDL in West Virginia stated that the company had come to a settlement agreement, but until early March, no amount of plaintiffs of money was known.
In that filing, Coloplast’s attorney told Judge Joseph R. Goodwin that the medical manufacturer had made “offers to five other groups [of plaintiffs] and we are optimistic we will be able to reach agreement on resolution.”
“We’d like to address the entire inventory so that we can buy our peace and move on down the road,” the attorney said, according to the transcript.
Johnson & Johnson’s Ethicon Unit has so far not indicated that they will pursue settlement talks in their transvaginal mesh MDL.“Ethicon is now focusing on trying to efficiently manage thousands of unverified and possibly unfounded complaints,” Sheri Woodruff, a spokeswoman for the Ethicon unit of New Brunswick, New Jersey-based J&J, said in an e-mail. The company will “request dismissal of meritless claims, including claims with no compensable injury, claims barred by the statute of limitations, misfiled claims, and improperly filed claims.”
According to a recent regulatory finding, J&J faces 12,250 transvaginal mesh injury claims in its MDL.
History of Transvaginal Mesh Problems
Transvaginal mesh was originally developed in 1996 and approved by the FDA for organ prolapse that caused vaginal pain and stress urinary incontinence. The original transvaginal mesh, Boston Scientific’s ProtoGen, was recalled in 1999, but due to an FDA approval loophole called 510(k) – which fast-tracks approval of devices similar to previously-approved devices – many other medical manufacturing companies began developing transvaginal mesh devices of their own.
Currently, there are six multidistrict litigations (MDLs) against six major medical manufacturers, with almost 50,000 plaintiffs claiming personal injury due to transvaginal mesh failure.
The Strom Law Firm Fights for Women in Transvaginal Mesh Personal Injury Case
Transvaginal mesh kits were initially produced to help with pelvic organ prolapse and stress urinary incontinence. Several varieties of mesh kits exist, but transvaginal mesh specifically was supposed to produce less scarring and pain, because the procedure was less invasive. However, vaginal mesh slings can cause a host of problems, including organ perforation, infection, internal scarring, continued organ prolapse, and bleeding. If you or a loved one has pelvic organ prolapse or stress urinary incontinence, have had a transvaginal mesh device implanted, and have since experienced detrimental complications, you may be entitled to compensation. The experienced lawyers at Strom Law, LLC can help. We offer free consultations, so please contact us today, and we can help get you on the road to recovery. 803.252.4800